Comparative Physicochemical Characterization and Biological Effects of Magnetite- and Maghemite-Based Magnetic Colloidal Suspensions in A704 Renal Cancer Cells
Background/Objectives: Magnetic iron oxide nanoparticles are investigated in cancer research; however, the direct biological effects of unloaded magnetic colloidal suspensions in renal cancer remain insufficiently characterized. This study compared two double-oleic-acid-coated formulations prepared from precursors: magnetite-based MCS 1 and maghemite-based MCS 2. Methods: The suspensions were characterized by vibrating-sample magnetometry, dynamic light scattering, bright-field scanning transmission electron microscopy, and energy-dispersive X-ray spectroscopy. Their effects on A704 renal adenocarcinoma cells were evaluated after 24 h of exposure to 1–5 µg/mL using MTT, neutral red uptake, JC-1, Hoechst 33342/MitoTracker Red CMXRos, acridine orange/propidium iodide staining, and a 7-day clonogenic assay. Results: MCS 2 showed higher volumetric saturation magnetization (1.541 vs. 1.059 Gs), a smaller Z-average hydrodynamic diameter (79.65 vs. 103.9 nm), and a more uniform volume-weighted distribution. Both formulations significantly reduced metabolic activity and neutral red uptake and induced mitochondrial depolarization, cell-death-associated morphological changes, and impaired clonogenic capacity. MCS 1 generally produced a moderate response with an apparent plateau, whereas MCS 2 showed a pronounced concentration-related effect at 4–5 µg/mL. At 5 µg/mL, MCS 2 reduced metabolic activity to approximately 49%, neutral red uptake to 50.04%, the JC-1 aggregate-to-monomer ratio to 46.02%, and colony formation to 31.44% of the control. Conclusions: The suspensions exhibited distinct physicochemical and biological profiles. MCS 2 produced greater effects at the highest concentrations, potentially related to its smaller hydrodynamic size and more uniform particle-size distribution. Further studies should establish tumor selectivity, cellular uptake, and the underlying molecular mechanisms.
Authors
- Vlad Socoliuc (ORCID: https://orcid.org/0000-0003-0529-1911)
- Elena-Alina Moacă (ORCID: https://orcid.org/0000-0002-2631-7028)
- Robert Ianoş (ORCID: https://orcid.org/0000-0001-5320-0522)
- Emil Radu Iacob (ORCID: https://orcid.org/0000-0002-5863-6613)
- Roxana Iacob (ORCID: https://orcid.org/0000-0002-2894-712X)
- Lucian Barbu–Tudoran (ORCID: https://orcid.org/0000-0003-0360-016X)
- Călin Marius Popoiu (ORCID: https://orcid.org/0000-0002-2535-2948)
- Mihai Cristian Neagu
- Stefan Marcu
- Andreea Smeu
- DIANA HAJ ALI
- Georgiana Boştinaru
Institutions
- Polytechnic University of Timişoara (RO)
- Babeș-Bolyai University (RO)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- National Institute of Research and Development for Electrochemistry and Condensed (RO)
- National Institute for Research and Development of Isotopic and Molecular Technologies (RO)
- Romanian Academy (RO)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-09-01
- DOI
- https://doi.org/10.3390/ph19091381
- Primary Topic
- Nanoparticle-Based Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministerul Cercetării, Inovării şi Digitalizării